616(top 1%)
papers
20.8K(top 1%)
citations
68(top 1%)
h-index
124(top 1%)
g-index
656
all documents
22.1K
doc citations
3.4K
citing journals

Top Articles

#TitleJournalYearCitations
1Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial functionProceedings of the National Academy of Sciences of the United States of America2007996
2Regulation of the Inflammatory Response in Cardiac RepairCirculation Research2012940
3TGF-β signaling in fibrosisGrowth Factors2011908
4Transforming growth factor (TGF)-β signaling in cardiac remodelingJournal of Molecular and Cellular Cardiology2011828
5Pathophysiology of Myocardial Infarction2015437
6Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic EvidenceJournal of Clinical Medicine2020411
7Acute Metformin Therapy Confers Cardioprotection Against Myocardial Infarction Via AMPK-eNOS–Mediated SignalingDiabetes2008373
8Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart FailureCirculation Research2009357
9Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failureJournal of the American College of Cardiology1999317
10Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injuryProceedings of the National Academy of Sciences of the United States of America2007306
11A new gaseous signaling molecule emerges: Cardioprotective role of hydrogen sulfideProceedings of the National Academy of Sciences of the United States of America2007304
12Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic PlaqueCirculation2020282
13Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signalingAmerican Journal of Physiology - Heart and Circulatory Physiology2008272
14Diabetic cardiomyopathyProgress in Cardiovascular Diseases1985261
15Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceKidney International2019232
16Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drugBlood2010224
17Prevalence and Characterization of Asymptomatic Pacemaker and ICD Lead Perforation on CTPACE - Pacing and Clinical Electrophysiology2007207
18Aging and Cardiac Fibrosis2011201
19Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunitiesTranslational Research2014200
20Maximally Recommended Doses of Angiotensin-Converting Enzyme (ACE) Inhibitors Do Not Completely Prevent ACE-Mediated Formation of Angiotensin II in Chronic Heart FailureCirculation2000199
21IL-1 Induces Proinflammatory Leukocyte Infiltration and Regulates Fibroblast Phenotype in the Infarcted MyocardiumJournal of Immunology2013194
22Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failureAmerican Journal of Cardiology1983168
23Accuracy of Transcranial Doppler for the Diagnosis of Intracardiac Right-to-Left ShuntJACC: Cardiovascular Imaging2014153
24Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failureJournal of the American College of Cardiology1986149
25Antimicrobial photodynamic inactivation in nanomedicine: small light strides against bad bugsNanomedicine2015148
26The Immune System and the Remodeling Infarcted HeartJournal of Cardiovascular Pharmacology2014137
27Demonstration of Left Ventricular Outflow Tract Eccentricity by Real Time 3D Echocardiography: Implications for the Determination of Aortic Valve AreaEchocardiography2007133
28Physical training in patients with chronic heart failure enhances the expression of genes encoding antioxidative enzymesJournal of the American College of Cardiology2001132
29The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial RegistryJournal of the American College of Cardiology2000129
30Experimental Diabetes Is Associated With Functional Activation of Protein Kinase Cε and Phosphorylation of Troponin I in the Heart, Which Are Prevented by Angiotensin II Receptor BlockadeCirculation Research1997125
31Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 8. Self-poisoning with beta-adrenoceptor blocking agents: recognition and managementAmerican Heart Journal1979124
32Demonstration of left ventricular outflow tract eccentricity by 64-slice multi-detector CTInternational Journal of Cardiovascular Imaging2009121
33Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failureAmerican Journal of Cardiology1981119
34Endogenous Thrombospondin 1 Protects the Pressure-Overloaded Myocardium by Modulating Fibroblast Phenotype and Matrix MetabolismHypertension2011119
35Cardiac malformations in the velocardiofacial syndromeAmerican Journal of Cardiology1980113
36Myostatin activation in patients with advanced heart failure and after mechanical unloadingEuropean Journal of Heart Failure2010113
37Endothelial Cell Activation in Patients With Decompensated Heart FailureCirculation2005112
38Beta3-Adrenoreceptor Stimulation Ameliorates Myocardial Ischemia-Reperfusion Injury Via Endothelial Nitric Oxide Synthase and Neuronal Nitric Oxide Synthase ActivationJournal of the American College of Cardiology2011111
39Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effectsAmerican Heart Journal1979108
40Impact of the New York State Cardiac Surgery and Percutaneous Coronary Intervention Reporting System on the management of patients with acute myocardial infarction complicated by cardiogenic shockAmerican Heart Journal2008108
41Role of electrophysiologic testing in the diagnosis and treatment of patients with known and suspected bradycardias and tachycardiasProgress in Cardiovascular Diseases1981107
42Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failureAmerican Journal of Cardiology1980106
43Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve ReplacementJACC: Cardiovascular Interventions2017106
44The role of the coronary collateral circulation in limiting myocardial ischemia and infarct sizeAmerican Heart Journal1993103
45Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a β-adrenoreceptor blockerAmerican Heart Journal197999
46Systematic Characterization of Myocardial Inflammation, Repair, and Remodeling in a Mouse Model of Reperfused Myocardial InfarctionJournal of Histochemistry and Cytochemistry201399
47Derived Indexes of Ventricular and Myocardial FunctionNew England Journal of Medicine197797
48Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applicationsAmerican Heart Journal197997
49Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor–Associated MyocarditisJournal of the American College of Cardiology202197
50Protective Effects of Activated Myofibroblasts in the Pressure-Overloaded Myocardium Are Mediated Through Smad-Dependent Activation of a Matrix-Preserving ProgramCirculation Research201996